Clarus Therapeutics Holdings, Inc.

CIK 1817944 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Clarus Therapeutics Holdings, Inc..

Recent SEC filings

FiledFormAccession number
Mar 6, 2023EFFECT9999999995-23-000526
Mar 6, 2023EFFECT9999999995-23-000525
Mar 6, 2023EFFECT9999999995-23-000522
Mar 6, 2023EFFECT9999999995-23-000524
Mar 1, 2023S-8 POS0001213900-23-015844
Mar 1, 202315-12G0001213900-23-015850
Mar 1, 2023POS AM0001213900-23-015842
Mar 1, 20238-K0001213900-23-015846
Mar 1, 2023POS AM0001213900-23-015836
Mar 1, 2023POS AM0001213900-23-015840
Mar 1, 2023POS AM0001213900-23-015838
Feb 22, 20238-K0001213900-23-013683
Feb 14, 2023SC 13G/A0001172661-23-001071
Jan 24, 20238-K0001213900-23-004819
Dec 22, 20228-K0001213900-22-082213
Nov 23, 20228-K0001213900-22-074705
Oct 31, 20228-K0001213900-22-067678
Oct 24, 20228-K0001213900-22-065838
Oct 18, 20228-K0001213900-22-064699
Sep 15, 20228-K0001213900-22-056275
Sep 14, 202225-NSE0001354457-22-000518
Sep 6, 20228-K0001213900-22-054293
Aug 26, 2022424B30001193125-22-231336
Aug 26, 2022424B30001193125-22-231364
Aug 26, 20228-K0001193125-22-231320